Navegando por Assunto "Genotoxicologia"

Agora exibindo 1 - 2 de 2

Acesso aberto (Open Access)
Análise imunológica e genotóxica em Rattus Novergicus da linhagem wistar tratados com ciclofosfamida
(Universidade Federal do Pará, 2016-08-11) CARVALHO, Heleniana Maria Miranda de; BURBANO, Rommel Mario Rodriguéz; http://lattes.cnpq.br/4362051219348099
The development of this work has given up due to the need to better understand the immune system, taking into account the diversity of experimental immunosuppression models as well as the variety of immunological responses and genotoxic differences these, related species, the drug and doses used. Thus, aim of this study was to analyze the effects on the immune system and genotoxic effects in Rattus norvegicus Wistar, after inoculation of the alkylating agent cyclophosphamide (CY). The administration of 50 mg / kg in rodents CY, possible to observe a significant decrease in the parameters of cellularity and relative weight of lymphoid organs. The humoral immunity of rodents has undergone deletion, since the analysis of the antibody titration was performed on the test plate forming cells and hemolysis testing. four inoculations that immunosuppressant and the intervals between the inoculations was determined by recovery of normal levels of the above parameters were performed. Both times the drug was administered, there was a reduction in the number of lymphocytes and neutrophils subsequently decreased, but only the second contact CY was observed immunosuppression. The analysis of the genotoxicity of cyclophosphamide (CY) was analyzed using the comet assay and was of paramount importance because dectamos genomic damage occurring in DNA exposed to different doses of cyclophosphamide (CY), which were 50 mg / kg in the first two phases and 25 mg / kg during the last two phases of the experiment. Furthermore, it was found that the genotoxic effects are cumulative with each CY dose applied, because even being administered in the third phase, the middle concentration (25 mg / kg) of the two inoculations initial CY the damage index does not correspond to half damage indices of the first and second vaccination. However, the analysis and immunologically genotoxicamente rodents, our work will enable testing new therapeutic immunosuppression regimens.
Acesso aberto (Open Access)
Modelo experimental de imunossupressão com ciclofosfamida em Rattus norvegicus da linhagem wistar e primatas não humanos da especie Cebus apella: análise genotoxicológica
(Universidade Federal do Pará, 2011-12-23) SOUZA, Patrícia Carvalho de; BURBANO, Rommel Mario Rodriguéz; http://lattes.cnpq.br/4362051219348099
We established a model of immunosuppression in rats by inoculation of the alkylating agent Cyclophosphamide (CY). The administration of 50 mg/kg CY in Wistar rats caused a significant decrease in the parameters of cellularity, and relative weight of lymphoid organs. For analysis of antibody titre of the test on the plaque forming cells and hemolysis test was proven that the humoral immunity of rodents suffered suppression. Four inoculations were carried out and this immunosuppressive intervals between inoculations was determined by recovery of normal levels of the aforementioned parameters. The change in differential counts of white blood cells represented the greatest adverse effect of CY, observed in laboratory parameters analyzed in Cebus apella. Both times it was administered the drug decreased the number of lymphocytes and neutrophils subsequently decreased, but only in the second was observed immunosuppression. Since the phylogenetic proximity of nonhuman primates, this experimental design is of paramount importance for the study of tumors at various stages of development and mainly for testing new drugs and therapeutic regimens. With respect to genotoxicity analysis of CY can conclude that in Wistar rats, the administration of CY significantly increased frequency of micronuclei in polychromatic erythrocytes (MN ECPs) and caused a cytotoxic effect (P <0.05). In C. apella, the peripheral blood lymphocytes after treatment with CY showed a significant increase in media MN/1000 lymphocyte cells compared to control (P <0.05). The concentration of 50mg/kg of CY in C. apella, LD50 is the concentration of the drug, whereas 50% of these animals died during the trial of immunosuppression. Until the development of this work, do not know the concentration corresponding to the LD50 in this species. In comparing the two species of animals used in this work, non-human primates have a more rapid immune recovery compared to rats. Probably the ability to metabolize the drug is more effective in C. apella. Our results support, therefore, that non-human primates are the best experimental models due to its great evolutionary and phylogenetic proximity to humans.